Given existing antidepressants don’t work for many people, the excitement surrounding the development of a new class of treatments from recreational drugs such as magic mushrooms is understandable. But there are strong reasons to doubt they will have the kind of impact hoped for. Instead, this article in New Science illustrates that we are more likely to be seeing the latest episode in a long-running saga of repeated disappointment. Read the full article here.